Fennec Pharmaceuticals Inc. (TSE:FRX – Get Free Report) shares crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$11.34 and traded as low as C$11.27. Fennec Pharmaceuticals shares last traded at C$11.27, with a volume of 100 shares trading hands. Fennec Pharmaceuticals Stock […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the firm’s stock in a transaction dated Thursday, July 6th. The stock was sold at an average price of $8.47, for a total transaction of $18,693.29. Following the completion of the transaction, the director now owns 28,826 shares in the […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) was the recipient of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 1,720,000 shares, an increase of 17.0% from the May 15th total of 1,470,000 shares. Approximately 7.9% of the shares of the stock are sold […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) Director Chris A. Rallis sold 1,758 shares of the firm’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $7.36, for a total transaction of $12,938.88. Following the sale, the director now owns 31,033 shares of the company’s stock, valued […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) – Stock analysts at Capital One Financial issued their FY2027 EPS estimates for Fennec Pharmaceuticals in a note issued to investors on Thursday, May 11th. Capital One Financial analyst N. Quibria forecasts that the company will post earnings per share of $2.68 for the year. The consensus estimate […]